Skip to main content
POM logo

POM · POMDOCTOR Ltd

Track POM — free
$0.97 -0.05 (-5.15%) At close · Aug 14
Market Cap
$8.13M
Shares
7.46M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.97 Open$1.02 Day$0.96–1.02 Since split$0.55–1.65 Avg vol 30d110K Short int19K · 0.3% float · 1.0d Short vol44% Last earningsJun 30, 2025 DataJun 2026–Aug 2026

Raw chart and full-history price indicators begin at the captured split on Jun 22, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Jun 22, 2026.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Buy Momentum Limited Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
RSI (14) 50
neutral
MACD trend Positive
52-week position 38%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-40% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.26% of float · ▼ -22.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — 13F breadth
Squeeze score 50
elevated · 0–100
Fundamentals
Weak
Gross margin 13%
EPS growth +3%
Y/Y
Free cash flow $-21.4M
Balance sheet $17.9M
net debt
Quant / Vol
risk profile
Very High
Volatility 166%
annualized · 1-yr
Max drawdown −67%
past year
ATR 16.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Prior guidance period ended · from the Earnings Call filed Jun 30, 2025
Operating earnings guidance for 2025 · 2025 $2.64 – $2.74

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 2
50 / 200-day cross
No cross Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
38% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-40% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.26% of float · ▼ -22.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — 13F breadth
Price context
position in its range since split · 2026-06-22
Range low $1 Now $1 · 38% Range high $2

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Pharmaceutical Retailers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
POM
POMDOCTOR Ltd
this stock
$8.13M 0.3%
RTEZ
REST EZ Inc.
$1.93B -100.0% 0.0%
HITI
High Tide Inc.
$205.00M -11.3% 1.0%
BHIC
BioScience Health Innovations, Inc.
$58.76M +208.3% 0.0%
SHFH
Scientist Home Future Health Ltd
$45.06M

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
6
% held
0.4%
Net QoQ
-20.4K sh
Top holder
CITADEL ADVISORS LLC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
19.0K
Days to cover
1.0d
Change
-5.4K sh
View
Short Volume
Short vol %
44%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
294
Value
$417
As of
Jul 14, 2026
View
Off-Exchange
Off-exchange %
61.6%
Week of
Jul 6, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
CNY 399.9M
EPS diluted
CNY -395.28
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 10, 2026
This year
15
View
Earnings & Events
Earnings Calls
Last call
Jun 30, 2025
View

Performance

Raw-price comparisons begin at the captured split on Jun 22, 2026; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
POM +11.9% -14.4% +75.9%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +11.5% -18.8% +72.0%
Key facts CIK 1877971 CUSIP 73181R207 13F (30d) 6 filings 6 filers Visit website